Literature DB >> 23839160

Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease.

Tingting Xie1, Xiaobing Cui, Haoxuan Zheng, Dong Chen, Ling He, Bo Jiang.   

Abstract

OBJECTIVE: The role of Helicobacter pylori infection in the pathogenesis of gastroesophageal reflux disease (GORD) is controversial. We aimed to confirm the negative association between H. pylori infection and endoscopic GORD and further determine whether eradication of the infection is associated with the development of endoscopic GORD.
MATERIALS AND METHODS: Case-control studies comparing the prevalence of H. pylori infection between patients with and those without GORD, type A cohort studies comparing the incidence of GORD between patients with and those without anti-H. pylori eradication therapy, and type B cohort studies comparing the incidence of GORD between H. pylori-positive patients with and those without successful eradication were included. Moreover, the effects of H. pylori eradication on the development of GORD in randomized-controlled trials were also analyzed.
RESULTS: Overall, 43 studies were analyzed. Case-control studies showed a lower prevalence of H. pylori infection in patients with GORD [odds ratio 0.64, 95% confidence interval (CI) 0.49-0.83]. Type A cohort studies showed an increased incidence of GORD in patients whose H. pylori infection was successfully eradicated [risk ratio (RR) 2.50, 95% CI 1.46-4.26]. Type B cohort studies showed that patients whose H. pylori had been eradicated had a higher risk of GORD (RR 1.70, 95% CI 1.30-2.23). Moreover, randomized-controlled trials showed that H. pylori eradication leads to a higher risk of GORD (RR 1.99, 95% CI 1.23-3.22); subanalyses showed that the risk existed especially in Asian studies (RR 4.53, 95% CI 1.66-12.36).
CONCLUSION: H. pylori infection shows a negative association with the development of endoscopic GORD. Eradication of the infection may be a risk factor for de-novo endoscopic GORD, especially in Asian populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839160     DOI: 10.1097/MEG.0b013e328363e2c7

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  22 in total

1.  Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats.

Authors:  Takahiro Masuda; Fumiaki Yano; Nobuo Omura; Kazuto Tsuboi; Masato Hoshino; Se Ryung Yamamoto; Shunsuke Akimoto; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2017-11-15       Impact factor: 3.199

2.  Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).

Authors:  Felipe Mazzoleni; Luiz Edmundo Mazzoleni; Carlos Fernando de Magalhães Francesconi; Guilherme Becker Sander; Pâmela Schitz Von Reisswitz; Tobias Cancian Milbradt; Rafael da Veiga Chaves Picon; Diego Mendonça Uchoa; Laura Renata De Bona; Huander Felipe Andreolla; Helenice Pankowski Breyer; Ronaldo Spinato Torresini; Eduardo André Ott; André Castagna Wortmann; Alexandro de Lucena Theil; Jonathas Stifft; Raquel Petrucci Zenker; Candice Franke Krumel; Matheus Truccolo Michalczuk; Alexandre De Araujo; Ane Paula Canevese; Nadja Volpato; Cristiano André da Silva; Pedro Guilherme Schaefer; Natacha Fleck Titton; Larisse Longo; Maria Isabel Edelweiss; Daniel Simon; Nicholas Joseph Talley
Journal:  Int J Obes (Lond)       Date:  2019-06-13       Impact factor: 5.095

3.  Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis.

Authors:  Huili Shen; Yijie Chen; Xiaohui Li; Jing Yan; Junjie Zhao; Demin Kong; Yanxia Shi; Zhihui Li; Jihong Wang; Na Shao; Zhenghui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-05       Impact factor: 2.650

4.  Eradication of Helicobacter Pylori Infections and GERD: A systematic review and meta-analysis.

Authors:  Wen-Ling Mou; Meng-Yao Feng; Li-Hua Hu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

Review 5.  Helicobacter pylori infection: new pathogenetic and clinical aspects.

Authors:  Krisztina Hagymási; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

6.  Typical and atypical symptoms of gastro esophageal reflux disease: Does Helicobacter pylori infection matter?

Authors:  Laurino Grossi; Antonio Francesco Ciccaglione; Leonardo Marzio
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 7.  Interactions between Helicobacter pylori and gastroesophageal reflux disease.

Authors:  Oya Yucel
Journal:  Esophagus       Date:  2018-08-27       Impact factor: 4.230

8.  Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese?

Authors:  Katsunori Iijima; Tomoyuki Koike; Tooru Shimosegawa
Journal:  Front Microbiol       Date:  2015-06-09       Impact factor: 5.640

9.  A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice.

Authors:  Yuji Aiba; Yasuhiro Nakano; Yasuhiro Koga; Kenji Takahashi; Yasuhiko Komatsu
Journal:  Microbiologyopen       Date:  2015-03-15       Impact factor: 3.139

10.  Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.

Authors:  Shivaram Prasad Singh; Vineet Ahuja; Uday C Ghoshal; Govind Makharia; Usha Dutta; Showkat Ali Zargar; Jayanthi Venkataraman; Amit Kumar Dutta; Asish K Mukhopadhyay; Ayaskanta Singh; Babu Ram Thapa; Kim Vaiphei; Malathi Sathiyasekaran; Manoj K Sahu; Niranjan Rout; Philip Abraham; Prakash Chandra Dalai; Pravin Rathi; Saroj K Sinha; Shobna Bhatia; Susama Patra; Ujjala Ghoshal; Ujjal Poddar; Venigalla Pratap Mouli; Vikram Kate
Journal:  Indian J Gastroenterol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.